OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
3
Results
Show all
Save search
Copy query
Show results for
Unknown
(2)
Proteomics
(1)
Organisms
Schizophyllum commune H4-8
(1)
Mycobacterium tuberculosis SP7
(1)
Oryza sativa Japonica Group
(1)
Crotalus durissus terrificus
(1)
Eriocheir sinensis
(1)
Candidatus Endoriftia persephonae
(1)
Mycobacterium tuberculosis SP10
(1)
Mycobacterium tuberculosis SP13
(1)
Cotesia typhae
(1)
Mycobacterium tuberculosis SP22
(1)
Enterobacter ludwigii
(1)
Corynebacterium diphtheriae bv. mitis str. ISS 3319
(1)
Chlamydomonas reinhardtii
(1)
Lama
(1)
Pyricularia oryzae P131
(1)
Enterococcus mundtii CRL35
(1)
Pongo pygmaeus
(1)
Oncorhynchus tshawytscha
(1)
Pseudomonas canadensis
(1)
Strongylocentrotus purpuratus
(1)
Influenza A virus (A/California/04/2009(H1N1))
(1)
Salmonella enterica subsp. enterica serovar Typhimurium
(1)
Homo
(1)
Bradyrhizobium diazoefficiens
(1)
Streptococcus pyogenes STAB901
(1)
Pseudomonas aeruginosa PAO1H2O
(1)
Megoura viciae
(1)
Human alphaherpesvirus 1 strain 17
(1)
Quercus petraea
(1)
Canis lupus
(1)
Repository
pride
(1)
Tissue
Cell culture
(1)
Technology Type
Mass Spectrometry
(1)
Shotgun proteomics
(1)
Publication Date
2021
(1)
Release Date
2013
(2)
Lab affiliation
Center for Network Systems Biology, Boston University School of Medicine, Boston, MA, United States.
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
In-vitro and in-vivo effects of an environmental PPARγ metabolic disruptor, triphenyl phosphate, on adipogenic differentiation and metabolic functions
Comparison of TPhP and Rosi exposure to adipocytes.
ORGANISM(S):
Mus musculus (Mouse)
2021-09-08
|
PXD012337
|
Pride
Phosphoproteomics
Metabolism
Proteomics
Cite
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.
Not available
S-EPMC3848248
|
biostudies-literature
Cite
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Not available
S-EPMC3596060
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
